The gross proceeds from the offering, before deducting the underwriters' fees and other offering expenses payable by the Company, are expected to be $5,100,000, or $5,865,000 if the over-allotment option is exercised in full. The Company intends to use the proceeds from the offering for working capital and other general corporate purposes. A preliminary prospectus supplement has been filed, and a final prospectus supplement will be filed, with the SEC and, when available, copies of the preliminary and final ...